Influence of IL10 (rs1800896) Polymorphism and TNF-α, IL-10, IL-17A, and IL-17F Serum Levels in Ankylosing Spondylitis

被引:21
|
作者
Braga, Matheus [1 ]
Lara-Armi, Fernanda Formaggi [1 ]
Neves, Janisleya Silva Ferreira [1 ]
Rocha-Loures, Marco Antonio [2 ]
Terron-Monich, Mariana de Souza [3 ]
Bahls-Pinto, Larissa Danielle [3 ]
de Lima Neto, Quirino Alves [1 ,3 ]
Zacarias, Joana Maira Valentini [1 ,3 ]
Sell, Ana Maria [1 ,3 ]
Visentainer, Jeane Eliete Laguila [1 ,3 ]
机构
[1] Univ Estadual Maringa, Dept Clin Anal & Biomed, Post Grad Program Biosci & Physiopathol, Maringa, Parana, Brazil
[2] Univ Estadual Maringa, Dept Med, Rheumatol Div, Maringa, Parana, Brazil
[3] Univ Estadual Maringa, Dept Basic & Hlth Sci, Immunogenet Lab, Maringa, Parana, Brazil
来源
FRONTIERS IN IMMUNOLOGY | 2021年 / 12卷
关键词
autoimmune disease; spondyloarthritis; rheumatological diseases; interleukin-10; interleukin-17; tumour necrosis factor alpha; single nucleotide polymorphisms; genetic polymorphism; SOCIETY CLASSIFICATION CRITERIA; MACROPHAGE PHENOTYPE; CYTOKINE PRODUCTION; ASSOCIATION; CELLS; SPONDYLOARTHRITIS; INTERLEUKIN-10; ARTHRITIS; AFRICAN; PARANA;
D O I
10.3389/fimmu.2021.653611
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Ankylosing spondylitis (AS) is a chronic autoimmune inflammatory disease that mainly affects the axial and sacroiliac joints. Single-nucleotide polymorphisms (SNPs) in genes encoding cytokines have been associated with AS, which can interfere with the production of these cytokines and contribute to the development of AS. In order to contribute to a better understanding of the pathology of AS, our objective was to investigate a possible association of the IL10 -1082 A>G SNP (rs1800896) with AS and to evaluate the serum levels of TNF-alpha, IL-10, IL-17A, and IL-17F in AS patients and controls comparing them with their respective genotypes (TNF rs1800629, IL10 rs1800896, IL17A rs2275913, and IL17F rs763780). Patients and controls were selected from the Maringa University Hospital and the Maringa Rheumatism Clinic, in Parana State, Southern Brazil, and they were diagnosed by the ASAS Criteria. In total, 149 patients and 169 controls were genotyped for the IL10 -1082 A>G polymorphism using a polymerase chain reaction with sequence specific primers (PCR-SSP); the measurement of TNF-alpha serum levels was performed through the immunofluorimetric test and IL-10, IL-17A, and IL-17F using an ELISA test. There was a high frequency of the IL10 -1082 G allele in AS patients compared with controls with an odds ratio of 1.83 and 95% confidence interval of 1.32 to 2.54, and a significant difference in the genotype frequencies of the IL10 -1082 A/G+G/G between patients and healthy controls, with an odds ratio of 3.01 and 95% confidence interval of 1.75 to 5.17. In addition, increased serum levels of IL-10 were observed in AS patients: 2.38 (IQR, 0.91) pg/ml compared with controls 1.72 (IQR 0.93) pg/ml (P = 0.01). Our results also showed an association between IL17F rs763780 C/T+T/T genotypes and increased serum levels of IL-17F in patients with AS and also in controls. We can conclude that patients with the A/G and G/G genotypes for -1082 A>G (rs1800896) in the IL10 gene are three times more likely to develop AS, that the serum level of IL-10 was higher in AS patients and that the IL17F rs763780 polymorphism can affect the levels of IL-17F in the serum of patients and controls in the same way.
引用
收藏
页数:8
相关论文
共 50 条
  • [11] Associations between polymorphisms of IL-17F and IL-17A genes with disease activity and clinical outcome of Ankylosing Spondylitis
    Inal, Erkol E.
    Gorukmez, O.
    Eroglu, S.
    Sag, Ozemri
    Solak, O.
    Gorukmez, O.
    Yakut, T.
    ACTA REUMATOLOGICA PORTUGUESA, 2016, 41 (03): : 232 - 239
  • [12] Serum concentrations of IL-17A, IL-17B, IL-17E and IL-17F in patients with systemic sclerosis
    Robak, Ewa
    Gerlicz-Kowalczuk, Zofia
    Dziankowska-Bartkowiak, Bozena
    Wozniacka, Anna
    Bogaczewicz, Jaroslaw
    ARCHIVES OF MEDICAL SCIENCE, 2019, 15 (03) : 706 - 712
  • [13] IL-10 rs1800896 Polymorphism: A Risk Factor for Adult Acute Lymphoblastic Leukemia
    Abdalhabib, Ezeldine K.
    Alzahrani, Badr
    Saboor, Muhammad
    Hamza, Alneil
    Elfaki, Elyasa M.
    Alanazi, Fehaid
    Alenazy, Fawaz O.
    Algarni, Abdulrahman
    Ibrahim, Ibrahim Khider
    Mohamed, Hozifa A.
    Alfeel, Ayman Hussein
    Alshaikh, Nahla Ali
    PHARMACOGENOMICS & PERSONALIZED MEDICINE, 2022, 15 : 809 - 815
  • [14] Amelioration of Systemic Amyloidosis by Blocking IL-17A and Not by IL-17F, and Arteriosclerosis by Blocking Both IL-17A and IL-17F in an Inflammatory Skin Mouse Model
    Nakanishi, Takehisa
    Iida, Shohei
    Ichishi, Masako
    Kondo, Makoto
    Nishimura, Mai
    Ichikawa, Ayaka
    Matsushima, Yoshiaki
    Iwakura, Yoichiro
    Watanabe, Masatoshi
    Yamanaka, Keiichi
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (21)
  • [15] Diagnostic value of il-1β, il-17a, and il-17f serum levels in patients with upper extremity infections
    Syngouna S.A.
    Mitsikostas P.
    Sioutis S.
    Bekos A.
    Fandridis E.
    Mavrogenis A.F.
    Tsiodras S.
    Pneumaticos S.
    Mavrogenis, Andreas F. (afm@otenet.gr), 1600, Begell House Inc. (31): : 39 - 44
  • [16] IL-17A and IL-17F in tissue homeostasis, inflammation and regeneration
    Iannis E. Adamopoulos
    Vijay Kuchroo
    Nature Reviews Rheumatology, 2023, 19 : 535 - 536
  • [17] Expression of IL-17A and IL-17F cytokines in B lymphocytes
    Vazquez-Tello, A.
    Nadigel, J.
    Mazer, B. D.
    Eidelman, D. H.
    Hamid, Q.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2010, 181
  • [18] IL-17A and IL-17F in tissue homeostasis, inflammation and regeneration
    Adamopoulos, Iannis E. E.
    Kuchroo, Vijay
    NATURE REVIEWS RHEUMATOLOGY, 2023, 19 (09) : 535 - 536
  • [19] Dual inhibition of IL-17A and IL-17F in psoriatic disease
    Iznardo, Helena
    Puig, Lluis
    THERAPEUTIC ADVANCES IN CHRONIC DISEASE, 2021, 12
  • [20] HUMAN (H161R) IL-17F MUTANT IS A DUAL ANTAGONIST OF IL-17A AND IL-17F
    Mittal, Gayatri A.
    Mageed, Rizgar A.
    Chernajovsky, Yuti
    RHEUMATOLOGY, 2011, 50 : 53 - 53